Volume 42, Issue 1 p. 147-159
Original Article

Evolution of Lung Abnormalities on Lung Ultrasound in Recovery From COVID-19 Disease—A Prospective, Longitudinal Observational Cohort Study

Julia Burkert MD, PhD

Corresponding Author

Julia Burkert MD, PhD

Chelsea and Westminster NHS Foundation Trust, London, England

Address correspondence to: Julia Burkert, MD, PhD, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, SW10 9NH London, England.

E-mail: [email protected]

Search for more papers by this author
Robert Jarman MD

Robert Jarman MD

Department of Emergency Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Teesside University, School of Health & Life Sciences, Middlesbrough, England

Search for more papers by this author
Paramjeet Deol MD

Paramjeet Deol MD

Department of Emergency Medicine, Chelsea and Westminster NHS Foundation Trust, London, England

Search for more papers by this author
First published: 15 April 2022
Citations: 1

We thank Dr. Hannah Dunlop and Dr. Alice Brown for their help with patient recruitment, organization of follow-up appointments and ultrasound scans.

Abstract

Objectives

SARS-CoV-2 can cause respiratory diseases with various manifestations. However, little is known about its potential for lung recovery. Lung ultrasound has shown characteristic changes during COVID-19 and has proven to be useful for triage, diagnosis, and therapy. This study investigated how the recovery process from COVID-19 respiratory disease can be monitored using 12-zone lung ultrasound.

Methods

This prospective observational cohort study was conducted in a busy urban emergency department in London, United Kingdom, over a 20-week period between April and October 2020. We followed 24 patients recovering from COVID-19 with varying disease severity using 12-zone lung ultrasound at 2-week intervals and monitored the changes in the prevalence of lung abnormalities previously described in COVID-19 infection (irregular pleura, subpleural consolidation, B-lines, and small localized effusions).

Results

Lung ultrasound showed that the lung recovers significantly over 20 weeks postdisease. Individual lung abnormalities also resolved at different rates. The entire rib space occupied by confluent B-lines wane after the acute phase, whereas irregular pleura and subpleural consolidations resolved more gradually. Separate wide B-lines moving with the pleura during respiration may represent more stable features, indicating residual fibrotic changes. Small, localized effusions appear transiently after the initial acute phase of the disease, peaking at approximately 10 weeks after infection. The measured lung abnormalities were strong predictors of perceived shortness of breath during ambulation.

Conclusion

Lung ultrasound can be a useful tool for long-term monitoring of COVID-19 lung disease, avoiding repeated exposure to ionizing radiation, and may distinguish between acute and past infections.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.